Institutional Career Development Core

自2008年开始以来，犹他州CCTS KL2计划的基本理念是通过提供 有前途的初级教员研究人员具有多维指导研究经验，使他们能够 发展、示范和传播促进健康的翻译科学。该项目吸引了学者 从犹他州CCTS的七所合作机构的大量候选人中挑选出来，并提供了一条途径 研究成功。最终的结果是创建了一支多元化的科学家团队，他们影响着地方和国家 从出生到临终的医疗保健优先事项。计划的影响体现在以下方面的研究工作效率上 67%的过去学者获得了额外的职业发展奖，总共发表了317项 稿件7,094篇(平均H指数为9.8)。 犹他州KL2项目未来五年的目标是培养有前途的初级教员。 取得研究成功。而研究成功的典型决定因素是达到R01 在国家卫生研究院的支持下，我们将K的定义扩大到研究成功，包括领导一项科学 研究企业&gt；每年支持20万美元，并开展有重大影响的研究 关于健康和医疗保健。我们将通过以下三个目标实现这一目标： 目标1：提高KL2学者取得“K对R同等成功”的比例，包括 在5年内提高R01等同奖项的PI比例(从17%提高到50%) 完成了他们的导师培训奖。 目的2增加犹他州CCTS KL2学者在医学(URM)中代表性不足的数量。 目标3：积极加强和扩大对现有临床和转化科学事业的利用 犹他州CCTS生态系统和全国CTSA网络内的发展机会。 项目设计的主要特点包括大学副校长的临床和翻译科学 (VPCAT)计划。这两年的密集经验为以下课程和指导奠定了基础 KL2学者运用整体矩阵辅导模式，制定个人发展计划 (IDP)和首席调查员管理要点培训(C)。我们将在这些功能的基础上 通过1)创建专门设计用于支持新的 追捕R01的调查人员，2)有针对性地招募那些在医学上代表性不足的人 从博士前水平开始，3)扩大犹他州CCTS社区外展资源的使用，并 加强与其他CTSA计划的联系。犹他州KL2董事、指导委员会和成立 外部咨询委员会将在该计划从两个NCAT扩展到四个NCAT时为其提供指导 支持学者，重点是增加群体的多样性。此外，我们还将添加 为那些额外资金将具有变革性的学者提供第三年支助的选择。

Since its inception in 2008, the Utah CCTS KL2 Program rationale has been to distinguish itself by providing promising junior faculty researchers with multidimensional mentored research experiences that enable them to develop, demonstrate, and disseminate translational science to advance health. The program draws scholars from the large pool of candidates in the seven Utah CCTS partnering institutions and provides a path to research success. The end result is the creation of a diverse team of scientists who impact local and national healthcare priorities from birth to end of life. Program impact is demonstrated by research productivity where 67% of past scholars have received additional career development awards and collectively have published 317 manuscripts with 7,094 citations (average H-index = 9.8). The objective of the Utah KL2 program for the next five years is to have promising junior faculty members achieve research success. While the typical determinant of research success is attainment of R01 level NIH support, we broaden the definition of K to Research success to include leading a scientific research enterprise of >$200,000 in annual support and conducting research with substantial impact on health and healthcare. We will realize this objective with the following three aims: Aim 1: Improve the proportion of KL2 scholars who achieve “K to R equivalent Success”, including increasing the proportion (from 17% to 50%) who are the PI on an R01 equivalent award within 5 years of completing their mentored training award. Aim 2 Increase the number of Utah CCTS KL2 Scholars who are underrepresented in medicine (URM). Aim 3: Proactively strengthen and expand use of existing clinical and translational science career development opportunities within the Utah CCTS ecosystem and the national CTSA network. Key program design features include the University’s Vice President’s Clinical and Translational science (VPCAT) program. This two year intensive experience provides the curricular and mentoring foundation for KL2 scholars by using the holistic Matrix Mentoring Model, development of an Individual Development Plans (IDP), and training in Management Essentials for Principal Investigators©. We will build on these features to accomplish our stated aims by 1) creating an institutional infrastructure specifically designed to support new investigators in pursuit of R01s, 2) implementing targeted recruitment of those underrepresented in medicine beginning at the pre-doctoral level, and 3) expand use of Utah CCTS community outreach resources and augment links with other CTSA programs. The Utah KL2 directors, Steering Committee, and established External Advisory Board will provide guidance for the program as it expands from two to four NCATS supported scholars, with a focus on increasing the diversity of the group. In addition, we will also add the option for a third year of support for scholars for whom the additional funding would be transformative.